Press "Enter" to skip to content

NICE extends recommendation for Lokelma in Hyperkalaemia

There is an increased risk of developing hyperkalaemia in patients with chronic kidney disease and heart failure compared to the general population and in particular some patients who take cardio-renal medications, such as renin-angiotensin-aldosterone …Read more





NICE expands draft recommendation for Lokelma

has announced that the National Institute for Health and Care Excellence NICE has issued a positive Final Appraisal Document FAD for Lokelma sodium zirconium cyclosilicate The FAD recommends the drug as an option for treating hyperkalaemia in adults
Read more

NICE says no to AZ and Vifors rival hyperkalaemia drugs

NICE has rejected rival treatments for high levels of potassium in the blood known as hyperkalaemia AZs Lokelma and Vifors Veltassa NICE says there is also no evidence to show that either drug extends life or improves quality of life compared
Read more

Dow Jones breaks through 25000

Search here Home Articles Newswires Videos All Videos BIOTECH CAPITAL TECH CAPITAL MINES MONEY WORLD OIL GAS MINING CAPITAL OIL CAPITAL
Read more

Measles Concerns Over Missed Vaccinations

Among announcements this week from the National Institute for Health and Care Excellence NICE was draft guidance to cover organising An assessment of the needs of carers was among new recommendations The guideline said it was important to consider
Read more

Management of Chronic Heart Failure in Adults Synopsis of the National Institute for Health and Clinical Excellence Guideline

Author Contributions Conception and design J Mant A Al-Mohammad P Larame Analysis and interpretation of the data J Mant A Al-Mohammad S Swain P Larame Drafting of the article J Mant A Al-Mohammad S Swain P Larame Critical
Read more

NICE turns down hyperkalaemia therapies

Both AstraZenecas Lokelma sodium zirconium to show that either drug extends life or improves quality of life compared with standard care in people who would have treatment for hyperkalaemia in the NHS NICE noted Because of the lack of relevant
Read more

Please follow and like us:

Comments are closed.